National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-IL-13 humanized monoclonal antibody TNX-650
A humanized monoclonal antibody directed against interleukin-13 (IL-13) with potential antineoplastic activity. Anti-IL-13 humanized monoclonal antibody TNX-650 binds to and blocks the activity of IL-13, which may result in the inhibition of Hodkin lympoma cell proliferation. IL-13 cytokine, an important mediator in allergic inflammation, may be an autocrine growth factor for Hodgkin lymphoma cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:monoclonal antibody TNX-650
Code name:TNX-650



Previous:anti-IGF-1 receptor human monoclonal antibody R1507, anti-IGF-1R fully human monoclonal antibody AMG-479, anti-IGF-1R recombinant monoclonal antibody BIIB022, anti-IGF-1R recombinant monoclonal antibody MK-0646, anti-IGF-1R recombinant monoclonal antibody SCH 717454
Next:anti-IL-6 chimeric monoclonal antibody, anti-KIR monoclonal antibody 1-7F9, anti-myeloma cell surface antigen immunoconjugate BT-062, anti-p53 T-cell receptor-transduced peripheral blood lymphocytes, anti-PD-1 human monoclonal antibody MDX-1106

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov